Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q85494496)
Watch
English
VEGF inhibition beyond tumour progression
scientific article published on 16 November 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
title
VEGF inhibition beyond tumour progression
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
main subject
tumor progression
1 reference
based on heuristic
inferred from title
author name string
Axel Grothey
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
publication date
16 November 2012
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
volume
14
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
page(s)
2-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
cites work
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970516-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970516-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970516-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970516-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970516-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(12)70516-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
PubMed publication ID
23168363
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23168363
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168363%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit